Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Fredric Coe and Joan Parks.

 
Connection Strength
 
 
 
2.466
 
  1. Parks JH, Coe FL. Evidence for durable kidney stone prevention over several decades. BJU Int. 2009 May; 103(9):1238-46.
    View in: PubMed
    Score: 0.437
  2. Parks JH, Worcester EM, O'Connor RC, Coe FL. Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int. 2003 Jan; 63(1):255-65.
    View in: PubMed
    Score: 0.291
  3. Parks JH, Goldfisher E, Asplin JR, Coe FL. A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol. 2002 Apr; 167(4):1607-12.
    View in: PubMed
    Score: 0.276
  4. Coe FL, Parks JH. Does a failure of crystal inhibition cause calcium renal stones? Nephron. 2002 Apr; 90(4):361-4.
    View in: PubMed
    Score: 0.276
  5. Parks JH, Coe FL, Evan AP, Worcester EM. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int. 2009 Mar; 103(5):670-8.
    View in: PubMed
    Score: 0.108
  6. Parks JH, Coe FL, Evan AP, Worcester EM. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant. 2009 Jan; 24(1):130-6.
    View in: PubMed
    Score: 0.107
  7. Worcester EM, Gillen DL, Evan AP, Parks JH, Wright K, Trumbore L, Nakagawa Y, Coe FL. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol. 2007 Jan; 292(1):F66-75.
    View in: PubMed
    Score: 0.096
  8. Worcester EM, Parks JH, Evan AP, Coe FL. Renal function in patients with nephrolithiasis. J Urol. 2006 Aug; 176(2):600-3; discussion 603.
    View in: PubMed
    Score: 0.093
  9. Worcester EM, Coe FL, Evan AP, Parks JH. Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis. BJU Int. 2006 Jun; 97(6):1285-90.
    View in: PubMed
    Score: 0.092
  10. Favus MJ, Karnauskas AJ, Parks JH, Coe FL. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab. 2004 Oct; 89(10):4937-43.
    View in: PubMed
    Score: 0.082
  11. Parks JH, Worcester EM, Coe FL, Evan AP, Lingeman JE. Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int. 2004 Aug; 66(2):777-85.
    View in: PubMed
    Score: 0.081
  12. Kuo RL, Lingeman JE, Evan AP, Paterson RF, Parks JH, Bledsoe SB, Munch LC, Coe FL. Urine calcium and volume predict coverage of renal papilla by Randall's plaque. Kidney Int. 2003 Dec; 64(6):2150-4.
    View in: PubMed
    Score: 0.077
  13. Worcester E, Parks JH, Josephson MA, Thisted RA, Coe FL. Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int. 2003 Dec; 64(6):2204-13.
    View in: PubMed
    Score: 0.077
  14. Asplin JR, Bauer KA, Kinder J, Müller G, Coe BJ, Parks JH, Coe FL. Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int. 2003 Feb; 63(2):662-9.
    View in: PubMed
    Score: 0.073
  15. Asplin JR, Parks JH, Nakagawa Y, Coe FL. Reduced crystallization inhibition by urine from women with nephrolithiasis. Kidney Int. 2002 May; 61(5):1821-9.
    View in: PubMed
    Score: 0.069
  16. Kinder JM, Clark CD, Coe BJ, Asplin JR, Parks JH, Coe FL. Urinary stone risk factors in the siblings of patients with calcium renal stones. J Urol. 2002 May; 167(5):1965-7.
    View in: PubMed
    Score: 0.069
  17. Bergsland KJ, Coe FL, Parks JH, Asplin JR, Worcester EM. Evidence for a role of PDZ domain-containing proteins to mediate hypophosphatemia in calcium stone formers. Nephrol Dial Transplant. 2018 05 01; 33(5):759-770.
    View in: PubMed
    Score: 0.053
  18. Worcester EM, Coe FL, Evan AP, Bergsland KJ, Parks JH, Willis LR, Clark DL, Gillen DL. Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients. Am J Physiol Renal Physiol. 2008 Nov; 295(5):F1286-94.
    View in: PubMed
    Score: 0.027
  19. O'Connor RC, Worcester EM, Evan AP, Meehan S, Kuznetsov D, Laven B, Sommer AJ, Bledsoe SB, Parks JH, Coe FL, Grynpas M, Gerber GS. Nephrolithiasis and nephrocalcinosis in rats with small bowel resection. Urol Res. 2005 May; 33(2):105-15.
    View in: PubMed
    Score: 0.021
  20. Evan AP, Lingeman JE, Coe FL, Shao Y, Parks JH, Bledsoe SB, Phillips CL, Bonsib S, Worcester EM, Sommer AJ, Kim SC, Tinmouth WW, Grynpas M. Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int. 2005 Feb; 67(2):576-91.
    View in: PubMed
    Score: 0.021
  21. Kim SC, Coe FL, Tinmouth WW, Kuo RL, Paterson RF, Parks JH, Munch LC, Evan AP, Lingeman JE. Stone formation is proportional to papillary surface coverage by Randall's plaque. J Urol. 2005 Jan; 173(1):117-9; discussion 119.
    View in: PubMed
    Score: 0.021
  22. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest. 2003 Mar; 111(5):607-16.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.